Dynavax Technologies
DVAX
#4989
Rank
NZ$3.09 B
Marketcap
NZ$26.32
Share price
0.00%
Change (1 day)
11.54%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -NZ$63.57 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are NZ$0.33 Billion. In 2024 the company made an earning of NZ$63.93 Million, an increase over its 2023 earnings that were of NZ$4.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$63.57 Million-199.41%
2024 NZ$63.93 M1475.31%
2023 NZ$4.05 M-99.2%
2022 NZ$0.51 B238.78%
2021 NZ$0.15 B-257.89%
2020 -NZ$95.41 Million-58.58%
2019 -NZ$0.24 Billion-9.32%
2018 -NZ$0.26 Billion60.44%
2017 -NZ$0.16 Billion-15.8%
2016 -NZ$0.19 Billion4.22%
2015 -NZ$0.19 Billion16.54%
2014 -NZ$0.16 Billion37.09%
2013 -NZ$0.12 Billion
2010 -NZ$80.82 Million214.85%
2009 -NZ$25.67 Million-37.33%
2008 -NZ$40.97 Million-66.07%
2007 -NZ$0.13 Billion16.92%
2006 -NZ$0.11 Billion170.36%
2005 -NZ$38.2 Million33.39%
2004 -NZ$28.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.30 B-30,175.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.24 B-26,587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.64 B-4,693.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.63 B-29,009.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.07 B-66,267.97%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$23.95 B-41,731.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$16.80 B-29,301.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
NZ$35.08 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.65 B-6,450.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel